ANI Pharmaceuticals Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
ANI Pharma (ANIP) Tops Q2 EPS by 16c, Updates Guidance
August 7, 2019 8:34 AM EDTANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $1.44, $0.16 better than the analyst estimate of $1.28. Revenue for the quarter came in at $54.4 million versus the consensus estimate of $55.2 million.
GUIDANCE:
ANI Pharma sees FY2019 EPS of $5.57-$6.21, versus the consensus... More
